DA Cheng Hua Chia has signed an agreement to acquire TAQKEY Science and Quantum Biotech, enhancing its position in the life sciences sector in Taiwan.

Target Information

DA Cheng Hua Chia has signed an agreement to acquire TAQKEY Science and Quantum Biotech, both based in Taiwan. This strategic move aligns with DA Cheng Hua Chia's goal of expanding its footprint in the life sciences sector and consumables business, thereby strengthening its competitive position as a leading global provider of scientific solutions.

Founded in 2002 and headquartered in Miaoli, Taiwan, TAQKEY Science and Quantum Biotech collectively employ over 60 staff members and generate annual net sales exceeding 13 million Swiss Francs. The companies boast a solid profitability record and have established long-term, stable partnerships with well-known brands in the life sciences industry. They operate seven business offices and three warehouses across Taiwan.

Industry Overview

The life sciences industry in Taiwan has been experiencing significant growth in recent years, fueled by advancements in biotechnology and healthcare. With a favorab

View Source

Similar Deals

大昌華嘉 德怡科技及量子生物科技

2025

Buyout Biotechnology & Medical Research (NEC) Other
DKSH Taqkey Science and Quantum Biotech

2025

Buyout Biotechnology & Medical Research (NEC) Other
DKSH Taqkey and Quantum

2025

Buyout Pharmaceuticals Wholesale Other
TELUS Health HUMANOO

2024

Buyout Healthcare Facilities & Services (NEC) Other
Mehiläinen Regina Maria and MediGroup

2024

Buyout Hospitals, Clinics & Primary Care Services Other
Adagia Partners Technoflex S.A.

2024

Buyout Drug Delivery Systems Other

大昌華嘉

invested in

德怡科技與量子生物科技

in 2025

in a Buyout deal

Disclosed details

Revenue: $36M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert